Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Sepsis Diagnostics Market Growth in 2025?

Recently, there has been significant growth in the size of the sepsis diagnostics market. It is estimated to increase from $0.99 billion in 2024 to $1.07 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The previous growth of this market can be credited to a rise in sepsis incidents, increased consciousness about the importance of early prognosis, an augmentation in healthcare spending, a greater occurrence of infections acquired in hospitals, and the expanded use of point-of-care testing.

What Is the Forecast for the Sepsis Diagnostics Market Size Through 2029?

In the forthcoming years, the sepsis diagnostics market is anticipated to exhibit robust growth. The market value is predicted to rise to $1.47 billion in 2029 with a compound annual growth rate (CAGR) of 8.2%. This growth trajectory during the forecast period is ascribed to factors such as the escalating demand for quick diagnostics, amplified investments in healthcare structures, heightened emphasis on individualized medicine, growing cases of antimicrobial resistance, and the increased utilization of next-generation sequencing. Notable trends projected during this period comprise the incorporation of AI in diagnostics, technological progress in biomarkers, progress in molecular diagnostics, transition towards automated and digital diagnosis platforms, and the evolution of artificial intelligence in diagnostic procedures.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23514&type=smp

What are the Key Market Players in Sepsis Diagnostics Market and How They’re Evolving?

Major companies operating in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMérieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., Sepsis Alliance

What Are the Primary Growth Drivers in the Sepsis Diagnostics Market?

The increasing occurrence of infections attained in hospitals is predicted to spur the expansion of the sepsis diagnostics market. Infections contracted in healthcare facilities, during or after a patient’s stay, normally 48 hours or more post-admission, which were absent upon admission, are termed as Hospital-acquired infections (HAIs). The amplification in the prevalence of these infections is attributed to the upsurge in antibiotic resistance developed due to the overrun and misuse of antibiotics in healthcare settings, contributing to the evolution of bacteria resistant to treatment, thereby making infections more challenging to treat. Sepsis diagnostics facilitate the early detection of such hospital-acquired infections by recognizing pathogens and biomarkers, enabling prompt medical intervention and minimising complications. For example, a report by the Australian Institute of Health and Welfare, a governmental agency based in Australia, in November 2024 stated that the recorded occurrence of HACs in 2022-23 was 2% for public hospital admissions and 0.8% for private ones, with the majority of complications being healthcare-associated infections. Thus, the escalating frequency of hospital-acquired infections propels growth in the sepsis diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23514&type=smp

What Are the Leading Segments in the Global Sepsis Diagnostics Industry?

The sepsis diagnostics market covered in this report is segmented –

1) By Product: Instruments, Blood Culture Media, Assay Kits And Reagents, Software

2) By Technology: Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Other Technologies

3) By Pathogen: Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, Other Pathogens

4) By Method: Automated Diagnostics, Conventional Diagnostics

5) By End-Users: Hospitals And Clinics, Pathology And Reference Laboratories, Research Institutes

Subsegments:

1) By Instruments: Automated Analyzers, Point-Of-Care (PoC) Testing Devices, Microfluidic-Based Devices, Polymerase Chain Reaction (PCR) Instruments, Flow Cytometers

2) By Blood Culture Media: Aerobic Blood Culture Media, Anaerobic Blood Culture Media, Mycobacteria Blood Culture Media, Pediatric Blood Culture Media, Fungal Blood Culture Media

3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Polymerase Chain Reaction (PCR) Assay Kits, Immunoassay Reagents, Molecular Diagnostic Reagents, Biosensor-Based Assay Kits

4) By Software: Data Management Software, Laboratory Information Systems (LIS), Artificial Intelligence (AI)-Based Diagnostic Tools, Predictive Analytics Software, Cloud-Based Diagnostic Platforms

What Are the Key Market Trends in the Sepsis Diagnostics Industry?

Primary players in the sepsis diagnostics market, such as Deepull Diagnostics S.L., are channeling their resources towards the creation of innovative solutions, namely culture-free diagnostic solutions. These novel solutions are designed to quickly and precisely detect sepsis without the reliance on the traditional blood cultures. Instead, they deploy modern technology like immunoassays, polymerase chain reaction (PCR), or next-generation sequencing (NGS) to swiftly identify pathogens straight from various patient samples, for example, blood, saliva, or tissue. A prime example of this is the introduction of the UllCORE diagnostic system by the Spain-based manufacturer, Deepull Diagnostics S.L., in April 2024. This system, a benchtop, culture-free multiplex PCR platform, was specifically crafted by Deepull to speed up pathogen identification in sepsis and other severe infections. Capable of extracting microbial DNA from 8 mL of unprocessed blood, the UllCORE delivers 50 observable results within 60 minutes. The system is adept at recognizing 95% of the pathogens responsible for causing sepsis, such as bacteria, fungi, and antibiotic-resistant genes. Besides enhancing early diagnosis, the UllCORE system also curbs the misuse of antibiotics, thereby aiding hospitals in their fight against antimicrobial resistance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/sepsis-diagnostics-global-market-report

What Is the Regional Outlook for the Sepsis Diagnostics Market?

North America was the largest region in the sepsis diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23514

This Report Delivers Insight On:

1. How big is the sepsis diagnostics market, and how is it changing globally?

2. Who are the major companies in the sepsis diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the sepsis diagnostics market right now?

4. Which products or customer segments are growing the most in the sepsis diagnostics market?

5. What factors are helping or slowing down the growth of the sepsis diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model